Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Cancer Metastasis Institute, Fudan University, Shanghai 200040, China.
Biomed Res Int. 2018 May 15;2018:8686027. doi: 10.1155/2018/8686027. eCollection 2018.
Liver cancer is the second leading cause of cancer-related death worldwide. The high frequency of recurrence and metastasis is the main reason for poor prognosis. Liver cancer stem cells (CSCs) have unlimited self-renewal, differentiation, and tumor-regenerating capacities. The maintenance of CSCs may account for the refractory features of liver cancer. Despite extensive investigations, the underlying regulatory mechanisms of liver CSCs remain elusive. miRNA and lncRNA, two major classes of the ncRNA family, can exert important roles in various biological processes, and their diverse regulatory mechanisms in CSC maintenance have acquired increasing attention. However, to the best of our knowledge, there is a lack of reviews summarizing these findings. Therefore, we systematically recapitulated the latest studies on miRNAs and lncRNAs in sustaining liver CSCs. Moreover, we highlighted the potential clinical application of these dysregulated ncRNAs as novel diagnostic and prognostic biomarkers and therapeutic targets. This review not only sheds new light to fully understand liver CSCs but also provides valuable clues on targeting ncRNAs to block or eradicate CSCs in cancer treatment.
肝癌是全球癌症相关死亡的第二大主要原因。复发和转移的高频率是预后不良的主要原因。肝癌干细胞(CSCs)具有无限的自我更新、分化和肿瘤再生能力。CSCs 的维持可能是肝癌难治性的原因。尽管进行了广泛的研究,但肝癌 CSCs 的潜在调节机制仍不清楚。miRNA 和 lncRNA 是 ncRNA 家族的两个主要类别,它们可以在各种生物学过程中发挥重要作用,它们在维持 CSC 中的多种调节机制引起了越来越多的关注。然而,据我们所知,目前缺乏对这些发现进行总结的综述。因此,我们系统地回顾了 miRNA 和 lncRNA 在维持肝 CSCs 中的最新研究。此外,我们强调了这些失调的 ncRNA 作为新型诊断和预后生物标志物和治疗靶点的潜在临床应用。本综述不仅为充分了解肝 CSCs 提供了新的思路,也为针对 ncRNA 以阻断或根除癌症治疗中的 CSCs 提供了有价值的线索。